Regarding the tumor progression-promoting mechanism of IFI6 at the molecular level, Cheriyath et al. [39] found that IFI6 regulated the balance between Bcl-2 and Bim expression to resist apoptosis. The gene discussed is BCL2L11; the disease is neoplasm.